Proto Script Pharmaceutical Corp.
PSCR · OTC
12/31/2016 | 12/31/2015 | 5/31/2014 | 5/31/2013 | |
|---|---|---|---|---|
| Market Cap | $88,278 | $9,296 | $9,296 | $9,233 |
| - Cash | $4 | $9 | $14 | $46 |
| + Debt | $51 | $36 | $0 | $0 |
| Enterprise Value | $88,325 | $9,323 | $9,283 | $9,187 |
| Revenue | $789 | $881 | $0 | $0 |
| % Growth | -10.5% | – | – | – |
| Gross Profit | $564 | $694 | $0 | $0 |
| % Margin | 71.5% | 78.8% | – | – |
| EBITDA | -$293 | -$71 | -$45 | -$38 |
| % Margin | -37.1% | -8% | – | – |
| Net Income | -$7,183 | -$145 | -$38 | -$32 |
| % Margin | -910.4% | -16.5% | – | – |
| EPS Diluted | -0.077 | -0.005 | -0.001 | -0.001 |
| % Growth | -1,493.8% | -269.2% | -18.2% | – |
| Operating Cash Flow | $44 | $38 | -$33 | -$32 |
| Capital Expenditures | -$15 | -$6 | $0 | $0 |
| Free Cash Flow | $29 | $32 | -$33 | -$32 |